Helping You Build Wealth With Honest Research
Since 1996. Read On...

The Best Asset Allocation for Your Equity Portfolio

Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Trusted by a Strong Community of Investors Since 2002
Access Our Premium Blue-Chip Recommendations


Get Instant Access

**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

AD

4 Largecap Stocks Bought by DIIs in Q4

Apr 28, 2026

4 Largecap Stocks Bought by DIIs in Q4Image source: mattjeacock/www.istockphoto.com

For years, Indian investors have seen markets react sharply to every foreign institutional investor (FII) inflow and outflow, with global sentiment often deciding the market's direction.

But early 2026 brought a noticeable change. Even as FIIs pulled out large amounts of capital, domestic institutional investors (DIIs) stepped in.

Large-cap stocks have been among the biggest beneficiaries of this trend. With strong business models, established market positions, and the ability to influence entire industries, these companies remain a preferred choice for institutional investors.

In this article, we will look at large-cap stocks bought by DIIs in Q4.

#1 PB Fintech

First on the list is PB Fintech.

The company is in the business of online marketing, information technology consulting, and support services. It's an online marketplace that offers end-to-end insurance and credit solutions to consumers.

It operates financial services portfolios, which include Policybazaar, Paisabazaar, and Pensionbazaar.

In the March 2026 quarter, the company witnessed a notable increase in DII holdings, which rose to 32.55% from 25.59% in the December 2025 quarter.

Particulars December 2025 Quarter March 2026 Quarter Change (percentage points)
DII Holding 25.5% 32.5% +6.96
Data Source: Ace Equity

This increased interest can be attributed to the company's strong Q3 FY26 performance. PB Fintech's revenue from operations grew 37% year-on-year (YoY) to Rs 17.7 bn, compared to Rs 12.9 bn in the same quarter last year.

The company also reported a sharp 165% rise in net profit to Rs 1.9 bn in the December quarter of FY26, supported by strong growth in new health and life insurance policies.

Overall premium growth stood at 45% during the quarter. In comparison, the Gurugram-based online insurance marketplace had reported a net profit of Rs 0.7 bn in the corresponding quarter of the previous financial year.

Going forward, the company plans to strengthen its healthcare ecosystem through PB Health by leveraging advanced AI technologies to improve healthcare accessibility and bridge critical gaps in the sector.

At the same time, it's driving growth through PB Partners, its agent aggregator platform, which supports independent sellers of insurance and other financial products, helping expand its reach across India.

For more details, see the POLICY BAZAAR PB FINTECH company fact sheet and quarterly results.

Want To Read The Full Article?

Enter your email to continue reading on Equitymaster.

Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster covering exciting investing ideas and opportunities in India.

Equitymaster requests your view! Post a comment on "4 Largecap Stocks Bought by DIIs in Q4". Click here!